A previous study and a gene-annotation enrichment analysis for potential targets of the microRNA miR-202-3p both suggest that this microRNA might be implicated in cardiovascular and metabolic diseases. In the present study, the role of miR-202-3p in the pathogenesis of coronary heart disease (CHD) was explored. We conduct a case-control study to detect the expression levels of miR-202-3p in peripheral blood cells and found that miR-202-3p expression was significantly higher in CHD cases than in controls (P < 0.001). miR-202-3p levels were negatively correlated with platelet distribution width (r = −0.348, P = 0.002) and mean platelet volume (r = −0.29, P = 0.01). Further functional analyses suggested that stimulation with oxidized low-density lipoprotein (ox-LDL) induced miR-202-3p expression, and that this microRNA suppressed the formation of ox-LDL-induced macrophage foam cells derived from THP-1 cells in a feedback manner. In addition, miR-202-3p overexpression modulated the expression of several key genes involved in foam cell formation, including that of ABCG4, NCEH1I, and SCARB2. In summary, miR-202-3p was associated with CHD, exerting a protective role against CHD by feedback suppression of ox-LDL-induced macrophage foam cell formation.
A therosclerotic cardiovascular diseases are the leading causes of mortality and morbidity worldwide. Coronary heart disease (CHD) is the most prevalent and high-impact atherosclerotic heart disease in China. 1) Although advances have been made in the understanding of the pathogenesis of CHD, the mechanistic details underlying the development of this disease require further investigation.
CHD is a complex disease for which both genetic and environmental factors contribute greatly. 2) In addition to the traditional risk factors of CHD, which include age, gender, smoking, drinking, history of hypertension, and diabetes mellitus, microRNAs (miRNAs), a type of epigenetic regulators, have attracted extensive attention. These molecules are well recognized as key regulators in pathogenic and pathological events of CHD, including foam cell formation, vascular inflammation, vascular cell proliferation, and migration. [3] [4] [5] Therefore, identification of CHD-related miRNAs and exploration of their pathogenic roles might enable us to better understand the pathogenic process of CHD, and develop novel biomarkers for CHD prevention. A previous study of our lab demonstrated the critical role of miR-202-3p in essential hypertension. 6) Numerous studies also indicated that miR-202-3p functions as a tumor suppressor in the carcinogenesis of multiple solid tumors including bladder, breast, colorectal, gastric, and pancreatic cancers. [7] [8] [9] [10] A gene-annotation enrichment analysis for potential targets of miR-202-3p suggested that it might be implicated in cardiovascular and metabolic diseases. We hypothesized that miR-202-3p might play a role in the pathogenic process of this complex metabolic disorder.
In this case-control study, we first analyzed the association between blood miR-202-3p levels and CHD risk in a Han Chinese population. Second, because the formation of macrophage foam cells is a key step in the occurrence and development of CHD, we examined the miR-202-3pmediated regulation of putative target genes implicated in this cellular process. The effects of miR-202-3p on the development of macrophage foam cells were also explored.
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Methods
Study design and population:
We recruited 81 consecutive CHD patients for miRNA profiling from the Second Affiliated Hospital of Nanchang University in Nanchang City, Jiangxi Province, China between November 2016 and August 2017. CHD was diagnosed as angiographically demonstrated stenoses (! 50%) in a major or main branch of the coronary artery as described previously. 11) Control participants (n = 81) were recruited among people who received a physical examination at the Second Affiliated Hospital of Nanchang University, frequency-matched by age and sex with the patients, and determined to be free of CHD and peripheral atherosclerotic arterial disease by medical history, clinical examinations, and electrocardiography (ECG).
Samples (5 mL) of fresh vein blood were collected from each participant using EDTA-anticoagulant tubes. The plasma and blood cells were separated by centrifugation at 2000 × g for 10 minutes at 4 , and then stored at −80 until use. Blood samples from patients with ischemic CHD were collected within 12 hours of hospital admission. Questionnaires were used by trained interviewers to collect general characteristics and results of clinical biochemistry tests for all participants. The study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki, and was approved by the ethics committee of the Second Affiliated Hospital of Nanchang University, and all participants provided written informed consent. miRNA expression assay: Approximately 200 μL of peripheral blood cells from the samples described above was used to extract total RNA with TRIzol LS reagent (Invitrogen) in accordance with the protocols provided by the manufacturer. The expression of miRNA was detected as previously described. 12) Target gene prediction: The miRNA target genes were predicted using the bioinformatics tool miRwalk3.0 (htt p://zmf.umm.uni-heidelberg.de/apps/zmf/mirwalk2/). 13) Cell culture, chemicals and transfection: Human acute monocytic leukemia cell line THP-1 cells, purchased from the type culture collection of the Chinese Academy of Sciences (Shanghai, China) were maintained in RPMI-1640 medium (Gibco) supplemented with 10% fetal bovine serum, sodium pyruvate, and GlutaMax. Phorbol-12myristate-13-acetate (PMA) was purchased from Beyotime Co., Ltd. (Shanghai, China). Oxidized (ox) low-density lipoprotein (LDL) was provided by Yiyuan Biotechnologies Co., Ltd (Guangzhou, China). miRNA mimics and inhibitors were synthesized by RioboBio Co., Ltd. (Guangzhou, Guangdong, China). miRNA mimics or inhibitors were transfected into cells using Lipofectamine 3000 (Invitrogen) in accordance with the manufacturer's protocol. All experiments were conducted with cells at a logarithmic stage of growth. Gene expression detection: For gene expression detection in cultured cells, total RNA was isolated using Trizol reagent (Invitrogen). First-strand cDNA was obtained using the SuperScript III First-Strand Synthesis System (Life Technologies). Quantitative PCR was conducted to detect gene expression using Platinum SYBR Green qPCR Su-permix (Life Technologies). The mRNA levels were normalized to β-ACTIN mRNA. The primers used for the gene amplification are shown in Supplemental Table I . Oil Red O staining: For differentiation of THP-1 cells into macrophages, cells were seeded into 6-well plates at 2 × 10 6 cells/well and cultured with RIPM-1640 containing 50 ng/mL PMA for 24 hours. Transfection with miRNA mimics or inhibitors was performed using Lipofectamine 3000. At 48 hours post transfection, the cells were stimulated with ox-LDL (50 μg/mL) to induce foam cell formation. After 24 hours of stimulation, the cells were fixed with 4% paraformaldehyde/phosphatebuffered saline and stained with Oil Red O solution provided by Leagene Biotechnology Co., Ltd (Beijing, China), following the manufacturer's protocol. The lipid content of THP-1 macrophage-derived foam cells was evaluated by microscopy. Statistical analysis: The normal distribution of data was tested by one-sample Kolmogorov-Smirnov test. Continuous variables are expressed as mean ± standard deviation (SD) or medians (25th-75th quartiles), and categorical variables are noted as frequencies. Comparisons of clinical characteristics between the case and control groups were examined by the χ 2 test for categorical variables, by Student's t-test for normally distributed data, and by the Mann-Whitney U test for skewed data. The difference in miR-202-3p expression between cases and controls as well as comparisons between two cell groups were examined by Student's t-test. The odds ratios (ORs) and 95% confidence intervals (CIs) were calculated to indicate the association between miR-202-3p and CHD risk, with adjustments for age, sex, smoking, drinking, hypertension, diabetes mellitus, and triglycerides (TG), using unconditional logistic regression analysis. The ability of miR-202-3p to discriminate CHD cases from controls was determined by the receiver operating characteristic (ROC) curve and reclassification analysis in two models as follows: the baseline model was composed of conventional risk factors, including age, sex, smoking, drinking, hypertension, diabetes mellitus, and TG, and the extended model incorporated the baseline model factors with miR-202-3p expression. Correlations between miR-202-3p expression and clinical parameters were analyzed by the Pearson's or Spearman's correlation test. All statistical analyses were performed using SPSS 12.0 software (Statistical Package for the Social Sciences; Chicago, IL, USA). A value of P < 0.05 was considered significant (2tailed).
Results
General characteristics of the study population:
The general characteristics of the case-control population are shown in Table I . The ages and sex ratios of the case and control groups were similar. The levels of uric acid (UA) were significantly higher in patients with CHD than in controls (P < 0.05). In contrast, the levels of total cholesterol (TC), high-density lipoprotein cholesterol (HDL-c), and LDL cholesterol (LDL-c) were significantly lower in patients than in controls (P < 0.05), possibly because of the use of cholesterol-lowering medications in the patient population. In addition, the proportion of history of hypertension or diabetes mellitus in CHD patients was higher than in controls (P < 0.05). No significant differences were found for the other variables. Association between miR-202-3p blood levels and CHD: As indicated in Figure 1 , the levels of miR-202-3p in peripheral blood cells were significantly higher in CHD patients than in controls (log-transformed expression levels relative to U6B, −1.42 ± 2.04 versus −2.67 ± 1.95, P < 0.001). Next, we conducted a logistic regression analysis to investigate the association between blood miR-202-3 p expression and CHD risk. The results indicated that higher levels of miR-202-3p were associated with an increased risk of CHD (adjusted OR, 1.37; 95% CI, 1.11 1.70; P = 0.004; CI, 0.82-0.93; P = 0.147). The net reclassification improvement (NRI) and integrated discrimination improvement (IDI) were calculated to determine the ability of miRNA to reclassify patients misclassified by the baseline model. The results showed that miR-202-3p was able to reclassify a significant portion of patients with an NRI of 50.5% (95% CI, 20.3-80.7; P = 0.0015) and an IDI of 0.04 (95% CI, 0.01-0.07; P = 0.0096). Correlation between miR-202-3p expression and clini-LI, ET AL cal variables: Conventional risk factors, including smoking, drinking, and history of hypertension or diabetes mellitus, contribute largely to the occurrence of CHD. However, we failed to observe any correlations between the blood levels of miR-202-3p and these factors (P > 0.05; Table III) . Mounting evidence has shown that fasting blood glucose (FG), lipids, and UA significantly influence the development and progression of CHD. Our examination did not find any correlations between blood miR-202-3p expression and TG, TC, HDL-c, LDL-c, FG, or UA among the CHD patients. Moreover, we also failed to find any correlation between blood miR-202-3p expression and renal function among the CHD patients and healthy subjects ( Supplemental Tables III, IV) . We further evaluated the correlations between miR-202-3p expression and platelet parameters, including platelet count (PLT), mean platelet volume (MPV), platelet distribution width (PDW) and plateletcrit (PCT). Interestingly, in CHD cases, we found that miR-202-3p expression was negatively correlated with PDW (r = −0.348; P = 0.002) and MPV (r = −0.29; P = 0.01). In control cases, miR-202-3p expression was negatively correlated with PDW (r = −0.274; P = 0.015) and PCT (r = −0.264; P = 0.018) (Supplemental Table V ). Prediction of putative mechanism for involvement of miR-202-3p in CHD development: CHD is characterized by the excessive deposition of lipids in the arterial intima. Imbalances in lipid influx, esterification, and efflux contribute largely to foam cell formation, which is widely considered to be a hallmark of atherosclerosis progression. Previous studies have identified several gene families involved in the uptake, metabolism, and export of cholesterol to modulate the development of foam cells and plaque formation, including the ABC gene families, acetyl-CoA acetyltransferases, carboxylesterases, choles-terol ester hydrolases, and scavenger receptors (Supplemental Figure 1A ). [16] [17] [18] [19] [20] [21] As shown in Supplemental Figure  1B , 3818 putative targets of miR-202-3p have been identified by miRWalK3.0. The intersection of Supplemental Figure 1A and B contained 15 putative targets, shown in Supplemental Figure 1C . After reviewing the literature, eight putative target genes (ABCA1, ABCG4, ACAT1, CES  1, LIPA, NCEH1, SR-B2, and SCARF1) with wellrecognized roles in the formation of foam cells were selected for further analyses. miR-202-3p regulation of foam cell formation: Because lipid-filled "foam cell" macrophages are an unusual yet characteristic feature of atherosclerotic lesions, we analyzed the role of miR-202-3p in macrophage foam cell formation. Modified LDLs are often considered as major triggers to promote foam cell formation and high circulating ox-LDL levels can be detected in patients of CVDs. 14, 15) First, to determine how endogenous miR-202-3 p might be regulated during foam cell development, we analyzed the endogenous levels of miR-202-3p in THP-1derived macrophages after 12 hours of ox-LDL stimulation. As Figure 2A shows, ox-LDL stimulation sharply upregulated miR-202-3p expression by about 3.5-fold. Next, we examined the effect of miR-202-3p on the internal lipid content of ox-LDL-induced foam cells. THP-1derived macrophages transfected with a miR-202-3p mimic or inhibitor were treated with ox-LDL to induce foam cell formation. After 48 hours of ox-LDL treatment, the cells were stained with Oil Red O solution and the lipid contents were evaluated. As shown in Figure 2B and Supplemental Figure 2 , miR-202-3p mimics reduced the lipid content and suppressed macrophage foam cell formation, whereas miR-202-3p inhibitors increase lipid content in ox-LDL-induced THP-1-derived foam cells.
miR-202-3p suppression of foam cell formation via modulation of ABCG4, NCEH1, and SR-B2 expression:
As mentioned above, miR-202-3p significantly suppressed the formation of THP-1-derived foam cells, and eight putative targets were involved in foam cell formation. To verify our hypothesis that miR-202-3p inhibits macrophage foam cell formation via modulation of these targets, THP-1-derived macrophages were transfected with miR-202-3p mimics or control mimics and subsequently treated with ox-LDL or left untreated. The endogenous expression of ABCA1, ABCG4, ACAT1, CES1, LIPA, NCEH1, SR-B2, and SCARF1 was examined using quantitative PCR. As shown in Figure 3B , miR-202-3p mimics led to a significant increase in ABCG4 and NCEH1 expressions, while SR-B2 expression decreased post miR-202-3p transfection in THP-1-derived macrophages, regardless of the presence or absence of ox-LDL. We also found that blocking miR-202-3p with its specific inhibitor significantly decreased the expression of ABCG4 in THP-1-derived macrophages (Supplemental Figure 3) . The sequence alignment of miR-202-3p with the target sites in the 3'UTRs of ABCG4, NCEH1, and SR-B2 are shown in Figure 3A . We did not detect any obvious fluctuations in the mRNA levels of ABCA1, ACAT1, CES1, LIPA, and SCARF1 (data not shown). Figure 2 . miR-202-3p suppressed oxidized low-density lipoprotein (ox-LDL) -stimulated foam cell formation in a feedback manner. THP-1 cells were differentiated into macrophages using 50 ng/mL phorbol-12-myristate-13-acetate (PMA). A: Cells were stimulated with 50 μg/mL ox-LDL for 12 hours. Relative levels of endogenous miR-202-3p measured by Taqman quantitative real-time PCR were normalized to the U6b standard. *P < 0.05 versus untreated. All data represent three independent experiments and are shown as mean ± standard deviation. B: After 24 hours of exposure to PMA, the cells were transfected with a miR-202-3p mimic or inhibitor. At 48 hours post transfection, the cells were stimulated with 50 μg/mL ox-LDL for 48 hours to induce macrophage foam cell formation and then stained with Oil Red O and hematoxylin. Macrophages were observed using an inverted microscope.
miR-202 ASSOCIATED WITH CHD INHIBITS FOAM CELL
Discussion
This study has revealed an anti-atherogenic role of miR-202-3p in CHD development. First, we found that miR-202-3p expression in peripheral blood was significantly higher in patients with CHD than in matched controls. Oil Red O staining assay suggested that miR-202-3p suppressed the formation of ox-LDL-induced, THP-1derived macrophage foam cells. Ox-LDL treatment also induced the expression of miR-202-3p in THP-1-derived macrophages, which could explain the elevated levels of miR-202-3p in CHD patients. Further bioinformatics analysis and cell transfection experiments revealed that miR-202-3p might inhibit foam cell formation via modulation of the expression of target genes including ABCG4, NCEH1, and SCARB2. Taken together, our data suggest that ox-LDL stimulation increased macrophage miR-202-3 p expression, thereby modulating the expression of ABCG 4, NCEH1, and SCARB2, ultimately leading to inhibition of foam cell formation induced by ox-LDL.
The formation of macrophage foam cells, a key step in the onset and development of CHD, occurs as a result of uncontrolled uptake of modified lipoproteins, excessive cholesterol esterification, and impaired cholesterol efflux. In the last decade, pioneering research has identified several key players involved in this process, such as scavenger receptors, ABC transporters, cholesterol acyltransferases, and cholesteryl ester hydrolases. In this study, we aimed to determine how macrophage foam cell development was blocked by miR-202-3p using assays to measure its effects on the expression of potential targets belonging to the gene families mentioned above. Our results showed that miR-202-3p downregulated SCARB2 expression and promoted the expression of ABCG4 and NCEH1. ABCG4 belongs to the ATP-binding cassette transporters superfamily, which promotes cholesterol efflux from cells to HDL. 22) NCEH1 is one of the major cholesteryl ester hydrolases in macrophages, whose depletion accelerates foam cell formation and aggravates atherosclerosis. 23) SCARB2, a scavenger receptor also called LIMP-2, is responsible for the transport of acid phospholipids, which contribute greatly to foam cell development. 24, 25) Thus, our findings suggest that miRNA-202-3p plays a role in atheroprotection via regulation of the uptake, metabolism, and release of macrophage cholesterol and phospholipids.
Platelets are pivotal players in the diverse pathogenic processes of CHD, and their importance in the different key steps of foam cell development is now widely accepted. Activated platelets modify native LDL by peroxidation, recruit monocytes from circulation, and facilitate macrophage extravasation. 26, 27) PDW and MPV are common platelet indices that have been identified as useful measures of platelet activation. 28, 29) Previous studies have associated PDW or MPV with the occurrence and severity of coronary artery disease. Interestingly, we observed that the whole blood cell levels of miR-202-3p were negatively correlated with PDW and MPV in the CHD patients, and that miR-202-3p expression was negatively correlated with PDW and PCT in the control cases. These results might indicate that miR-202-3p suppressed macrophage foam cell formation via both modulating cholesterol metabolism and controlling platelet activation. It is important to highlight the role of ABCG4 in platelet production. As Murphy reported, ABCG4 deficiency leads to accelerated atherosclerosis and thrombosis in association with increased platelet counts in LDL null mice. 30) The throm-LI, ET AL Figure 3 . miR-202-3p regulation of ABCG4, SR-B2, and NCEH1 expression in phorbol-12-myristate-13-acetate (PMA)-differentiated THP-1 macrophages. THP-1 cells were differentiated into macrophages using 50 ng/mL PMA. After 24 hours of exposure, the cells were transfected with a negative control (NC) mimic or a miR-202-3p mimic. At 48 hours post transfection, the cells were stimulated with 50 μg/mL ox-LDL for 12 hours. A: Sequence alignment of the miR-202-3p mature sequence with the 3'UTRs of ABCG4, SR-B2, and NCEH1. B: Expression of ABCG4, SR-B2, and NCEH1 mRNA as detected by quantitative RT-PCR, normalized to β-ACTIN. *P < 0.05; ***P < 0.005 versus control. All data represent three independent experiments and are shown as mean ± standard deviation.
bopoietin receptor C-MPL expression increased on the surface of megakaryocyte progenitors, resulting in a remarkable increase in platelet production in an ABCG4dependent manner. In the present study, we identified ABCG4 as a target of miR-202-3p, and the miR-202-3p levels were negatively correlated with PDW. Therefore, we suggest that miR-202-3p might also exert an atheroprotective effect by upregulating ABCG4 expression to modulate altered platelet production driven by chronic inflammation.
However, certain limitations should also be addressed. First, the study sample was not sufficiently large, and further studies are needed to replicate our results in a larger sample size population. Second, not all of the control participants had coronary angiography, introducing the possibility of false-negative cases. However, our controls had normal ECGs, no clinical symptoms, and no history of CHD before enrollment; thus, false negatives are likely to be rare. Third, we transfected miR-202-3p mimics to increase miR-202-3p intracellular levels to inhibit foam cell formation and realized that miR-202-3p overexpression might not be a physiopathological event. Further research is required to explore its role in CHD development under physiological and pathological conditions. Finally, the biological consequence of miR-202-3p depletion on plaque formation and progression should be evaluated in future studies using atherosclerotic mouse models.
Conclusions
In summary, the present study revealed the association between elevated blood cell levels of miR-202-3p and CHD. Combinations of blood miR-202-3p levels with traditional risk factors significantly improve the predictive miR-202 ASSOCIATED WITH CHD INHIBITS FOAM CELL value of CHD. Moreover, our findings also indicated that miR-202-3p exerted a protective role against CHD by feedback suppressing ox-LDL-induced macrophage foam cell formation.
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